2002
DOI: 10.1097/00004424-200209000-00002
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro Characterization of Two Different Ultrasmall Iron Oxide Particles for Magnetic Resonance Cell Tracking

Abstract: Citrate-coated USPIO particles VSOP-C125 appear to have more favorable properties for magnetic labeling of macrophages than the carboxydextran-coated USPIO preparation DDM 43/34/103.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
57
0

Year Published

2003
2003
2017
2017

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 98 publications
(58 citation statements)
references
References 28 publications
1
57
0
Order By: Relevance
“…[39][40][41][42][43][44] Earlier produced as VSOP-C184 (Ferropharm, Teltow, Germany), 45 these have been used for MSC labeling and found to have a detection limit of 40,000 cells in an 11.7 T MRI setting. 46 These NPs are no longer available.…”
Section: Introductionmentioning
confidence: 99%
“…[39][40][41][42][43][44] Earlier produced as VSOP-C184 (Ferropharm, Teltow, Germany), 45 these have been used for MSC labeling and found to have a detection limit of 40,000 cells in an 11.7 T MRI setting. 46 These NPs are no longer available.…”
Section: Introductionmentioning
confidence: 99%
“…Iron particle incorporation by the cells causes a strong decrease in the transverse relaxation time, which results in signal loss in T2*-weighted MR imaging (Arbab et al, 2003;Bowen et al, 2002;Renshaw et al, 1986). No apparent long-term cytotoxic effects were observed after using the particles both in vitro and in vivo (Fleige et al, 2002;Stroh et al, 2004 and. For magnetic labeling sterile VSOP are added to the incubation medium.…”
Section: Concept 1: Cell Labeling For Mri-based Tracking In Vivo 41mentioning
confidence: 99%
“…7 In addition, VSOP can reliably mark specific cells and assist in their subsequent detection in in vivo migration. [8][9][10] It was thus possible to monitor implanted VSOP-labeled neuronal progenitors over 6 weeks For that purpose, neutrophil granule cells and T cells were tagged with nanoparticles ex vivo, intravenously injected, and traced via MRI at inflammatory sites. [13][14][15] Although VSOP have been tested in clinical phase II trials, further assessment of cytotoxic effects is crucial.…”
Section: Introductionmentioning
confidence: 99%
“…However, after hippocampal slice preparation, microglia can diminish the amount of trauma-induced dead cells 10-fold within 7 days. 60 Thus, the increased PI signal can also be attributed to the absence of microglia and the deficient disposal of decaying cells (7)(8)(9). With regard to the exclusively SPIO-treated samples, VSOP-R1 significantly decreased viability in all regions of interest, whereas VSOP-R2 affected CA3 alone ( Figure 4S, T, and V).…”
mentioning
confidence: 97%